Julie Van Ongevalle

Julie Van Ongevalle is the CEO of Opella, a pharmaceutical company that produces popular over-the-counter medications including Doliprane. She has been in the news following the announcement of Opella's official separation from Sanofi, where she assured stakeholders that the production of Doliprane would remain in France despite new American ownership.